|
|
THIRD NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT
October 12 - 14, 2011
ONSITE
Mandarin Oriental
Washington, DC
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
|
COMPARATIVE EFFECTIVENESS SUMMIT ONLINE ARCHIVE LOG IN
|
|
Click here to log into Comparative Effectiveness video archive.
|
|
GRANTORS
|
|
DIAMOND
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
CO-LOCATED WITH
|
FIRST NATIONAL BUNDLED PAYMENT SUMMIT
|
A Hybrid Conference and Internet Event
The Leading Forum on the Role of Healthcare Payment Reforms with Special Focus on Bundled Payment Approaches
Sponsored by the Integrated Healthcare Association
October 12 - 14, 2011
Mandarin Oriental
Washington, DC
www.BundledPaymentSummit.com
|
|
|
FEATURING PRECONFERENCE ON
|
|
Communicating Comparative Effectiveness Data to Physicians and Patients: Academic Detailing and Shared Decision Making
|
|
AND SPECIAL SESSIONS ON
|
|
The Role of the Patient-Centered Outcomes Research Institute (PCORI)
The Role of AHRQ in Comparative Effectiveness Research
The Role of NIH in Comparative Effectiveness Research
How States are Already Using Comparative and Cost-Effective Research
Comparative Effectiveness Research and Personalized Medicine
How to Frame CER Research Priorities, Inclusion/Exclusion of Cost Issues, and Formatting of Products
Methods and Data Infrastructure Needed for CER
Practice-Based Evidence Study Design for Comparative Effectiveness Research
The Role of Comparative Effectiveness Research in Health Plan Operations
Systematic Reviews of Comparative Effectiveness: The Payor View
How Real World Evidence can help Payers Supplement Randomized Trial Data to make Informed Formulary Decisions
Heterogeneous Treatment Effects and the Implications of Average-Based Policies
Asymmetries in Access to Data, Evidence Thresholds and the Ability to Convey Information
The Impact of Comparative Effectiveness Research on Future Innovation
The Impact of Comparative Effectiveness Research on Innovation in new Technologies
The Impact of CER on Pharmaceutical Innovation, Value of Health and Longevity
How to Reward Innovation and Value in Comparative Effectiveness Research
The Role of Comparative Effectiveness Research in Value-Based Insurance Design
How Comparative Effectiveness Research can be Used by ACOs
The Role of Comparative Effectiveness Research in Provider Payment Reform
The Implications of CER for Complementary and Alternative Medicine
Comparative Effectiveness Research from the Patient Perspective
Comparative Effectiveness Research and Shared Decision Making
How Kaiser Uses Comparative Effectiveness Research in Patient Care
|
FREE SUBSCRIPTION TO MONTHLY
COMPARATIVE EFFECTIVENESS eNEWSLETTER
|
Click here to subscribe to a monthly Accountable Care Update eNewsletter, one of a family of free eNewsletters providing a complimentary video presentation and regularly updated news and key resources on major health care issues. To view and subscribe to other eNewsletters on patient safety, ACOs, Medicaid, pay for performance, and readmissions, go to www.HealthCareeNewsletters.com.
|
|
THIRD NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT
October 12 - 14, 2011
|
ONSITE
Mandarin Oriental
Washington, DC
|
OR |
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
 |
|
|
|
KEYNOTE SPEAKERS
|
Carolyn M. Clancy, MD
Director, Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services, Washington, DC |
Michael Lauer, MD
Director, Divisions of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD |
Joe V. Selby, MD, MPH
Executive Director, Patient-Centered Outcomes Research Institute, Former Director of the Research Division, Kaiser Permanente, Northern California, Washington, DC
|
|
|
|
|
SUMMIT CO CHAIRS
|
Robert W. Dubois, MD, PhD
Chief Science Officer, National Pharmaceutical Council, Reston, VA |
John Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC |
Paul Wallace, MD
Senior Vice President and Director of the Center for Comparative Effectiveness Research, The Lewin Group, Washington, DC
|
|
|
|
|
FEATURED FACULTY
|
Edward Abrahams, PhD
President, Personalized Medicine Coalition, Former Executive Director, Pennsylvania Biotechnology Association, Washington, DC |
Jerry Avorn, MD
Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Author, "Debate About Funding Comparative Effectiveness Research," New England Journal of Medicine, Boston, MA |
Michael J. Barry, MD
President, Foundation for Informed Medical Decision Making, Director of the Health Services Research Program and Chief, General Medicine Unit and Medical Director, John D. Stoeckle Center for Primary Care Innovation, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School, Boston, MA
|
Ian D. Coulter, PhD
Samueli Institute Chair in Policy for Integrative Medicine and Senior Health Policy Analyst, The RAND Corporation, Professor, School of Dentistry, UCLA, Research Professor, Southern Calif. University of Health Sciences, Santa Monica, CA |
John Doyle, PhD, MPH
Vice President, Practice Leader, Consulting Solutions, Quintiles, New York, NY |
A. Mark Fendrick, MD
Co-Director, University of Michigan Center for Value-Based Insurance Design and Professor in the Departments of Internal Medicine and Health Management and Policy, University of Michigan, Ann Arbor, MI
|
Michael A. Fischer, MD, MS
Assistant Professor of Medicine, Harvard Medical School, Director, National Resource Center for Academic Detailing, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA |
Mark Gibson
Deputy Director, Center for Evidence-Based Policy, Oregon Health and Science University, Program Officer, Milbank Memorial Fund, Former Chief of Staff, Oregon Senate President John Kitzhaber, Portland, OR |
Robert M. Goldberg, PhD
Co-Founder and Vice President, Center for Medicine in the Public Interest, New York, NY
|
Dana Goldman, PhD
Director, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, RAND Chair in Health Economics and Director of Health Economics, RAND, Los Angeles, CA |
Cliff Goodman, PhD
Senior Vice President and Principal, The Lewin Group, Chair, Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), Centers for Medicare & Medicaid Services, Washington, DC |
Scott Gottlieb, MD
Medical Internist, Stamford Hospital, Former Deputy Commissioner for Medical and Scientific Affairs, Food and Drug Administration, Former Senior Adviser to the Administrator, CMS, Stamford, CT
|
Jessie C. Gruman, PhD
Founder and President, Center for Advancing Health, Co-editor, Journal of Participatory Medicine, Washington, DC |
Carol Havens, MD
Director of Clinical Education, Kaiser Permanente Northern California, Sacramento, CA |
Susan D. Horn, PhD
Senior Scientist, Institute for Clinical Outcomes Research, Vice President of Research, International Severity Information Systems, Inc. (ISIS), Salt Lake City, UT
|
Jeffrey C. Lerner, PhD
President and Chief Executive Officer, ECRI Institute, Plymouth Meeting, PA |
Sharon Levine, MD
Associate Executive Director, The Permanente Medical Group of Northern California, Member, Board of Governors, Patient-Centered Outcomes Research Institute (PCORI), Oakland, CA |
Lorna A. Lynn, MD
Director of Recertification, American Board of Internal Medicine, Philadelphia, PA
|
Lyn Paget
Director of Policy and Outreach, Foundation for Informed Medical Decision Making, Boston, MA |
Barry Patel, PharmD
President and Co-Founder, Total Therapeutic Management, Kennesaw, GA |
Doris Peter, PhD
Manager, Consumer Reports Ratings Center and Principal Investigator, Consumer and Prescriber Education Grant Project, Consumer Reports, Yonkers, NY
|
Edmund Pezalla, MD, MPH
National Medical Director for Pharmaceutical Policy and Strategy, Aetna, Former Chief Clinical Officer, Aetna Pharmacy Management, Hartford, CT |
Hoangmai H. Pham, MD, MPH
Director of ACO Programs, Center for Medicare and Medicaid Innovation, Center for Medicare and Medicaid Services, Former Co-director for Research, Center for Studying Health System Change, Baltimore, MD |
Steven D. Pearson, MD, MSc, FRCP
President, Institute for Clinical and Economic Review (ICER), Harvard Medical School, Former Special Advisor, Technology and Coverage Policy, Centers for Medicare and Medicaid Services, Boston, MA
|
Eugene C. Rich, MD, FACP
Senior Fellow and Director, Center on Health Care Effectiveness, Mathematica Policy Research, Clinical Professor of Medicine, Creighton University School of Medicine, Washington, DC |
Tom Snedden
Director, Pharmaceutical Assistance, Contract for the Elderly (PACE), Commonwealth of Pennsylvania, Harrisburg, PA |
Brian Sweet, RPh, MBA
Executive Director, Development, AstraZeneca Pharmaceuticals, Former Chief Pharmacy Officer, WellPoint, Grand Island, NY
|
Sean Tunis, MD, MSc
President and Chief Executive Officer, World Trade Center Baltimore; Former Director, Office of Clinical Standards and Quality and Chief Medical Officer, Centers for Medicare and Medicaid Services, Baltimore, MD |
John A. Vernon, PhD
Assistant Professor Health Policy and Management, Gillings School of Global Health, University of North Carolina at Chapel Hill, Raleigh, NC
|
|
|
|
|
|
